India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
The seventeen-year-old Apoorv Kamble has emerged victorious at the FIDE rated rapid chess championship where…
The Bihar Vidya Sathi mobile application has been introduced to offer continuous academic assistance to…
Expenses incurred at the time of marriage may be too high for financially strapped families.…
Karnali is considered as one of the most significant rivers in Nepal and acts as…
This time US Open 2026 will set to create the history in the Grand Slam…
The Meghalaya Legislative Assembly on Wednesday adopted a resolution rejecting the exploration and mining of…